A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice

Journal of Leukocyte Biology

Volumn 68, Issue 4, 2000, Pages 538-544

  Briscoe, H ^a   Roach, D R ^a   Meadows, N ^a   Rathjen, D ^a   Britton, W J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cytokine; Granuloma; Macrophages; Mycobacteria; Nitric oxide

Indexed keywords

ARGININE DERIVATIVE; CD4 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; N MONOMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OKT 4; RECEPTOR ANTIBODY; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR[70-80]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOSTASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; ENZYME INDUCTION; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE DEPLETION; MACROPHAGE; MEDIATOR RELEASE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BIOLOGICAL RESPONSE MODIFIERS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FEMALE; HUMAN; INTERFERON TYPE II; LYMPHOCYTE DEPLETION; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PEPTIDE FRAGMENTS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RECURRENCE; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPPORT, NON-U.S. GOV'T; TUBERCULOMA; TUBERCULOSIS; TUMOR NECROSIS FACTOR;

EID: 0033780501     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Tuberculosis in the tropics
2. The global tuberculosis situation and the new control strategy of the World Health Organisation
3. Global surveillance for antituberculosis-drug resistance, 1994-1997
4. Immunity to intracellular mycobacteria
5. Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice
6. + depletion or by prior infection with murine AIDS retroviruses
7. Mechanisms of recrudescence of Mycobacterium bovis (BCG) infection in mice
8. Incidence of Mycobacterium avium-intracellulare complex bacteria in human immunodeficiency virus-positive patients
9. Incidence of tuberculosis in the United States among HIV-infected persons. The pulmonary complications of HIV infection study group
10. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection
11. Disseminated tuberculosis in interferon-γ gene disrupted mice
12. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis
13. Treatment of multidrug-resistant pulmonary, tuberculosis with interferon-γ via aerosol
14. Activation of tuberculostatic macrophage functions by gamma-interferon, interleukin-4 and tumour necrosis factor
15. Stimulation of antibacterial macrophage activities by B cell stimulatory factor 2/interleukin 6
16. Tumour necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates
17. Killing of Mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol
18. Structural deficiencies in granuloma formation in tumor necrosis factor gene-targeted mice underlie the heightened susceptibility to aerosol infection, which is not compensated for by lymphotoxin
19. Tumour necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
20. Exacerbation of acute and chronic murine tuberculosis by administration of a tumour necrosis factor receptor-expressing adenovirus
21. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection
22. Disseminated Mycobacterium avium infection in a child with decreased tumour necrosis factor production
23. Modulation of Mycobacterium avium growth in vivo by cytokines: Involvement of tumor necrosis factor in resistance to atypical mycobacteria
24. The common mediator of shock, cachexia and tumour necrosis
25. Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNF-α by different tumour cell receptors
26. Differential effects of small tumour necrosis factor-α peptides on tumour cytotoxicity, neutrophil activation and endothelial cell procoagulant
27. A synthetic tumour necrosis factor-α agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium faciparum in vitro and suppresses Plasmodium chabaudi infection in mice
28. A mild procedure for solid phase peptide synthesis: Use of fluorenylmerhoxycarbonyl amino acids
29. TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-ID4 rhabdomyosarcoma cells
30. 15N nitrate in biological fluids
31. Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo
32. Crystal structure of the soluble human 55 kD TNF receptor-human TNF beta complex: Implications for TNF receptor activation
33. Tumour necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide dependent fashion
34. The tumour necrosis factor ligand and receptor families
35. Unimpaired autoreactive T-cell traffic within the central nervous system during tumour necrosis factor receptor-mediated inhibition of experimental autoimmune encephalitis
36. Protection against endotoxic shock by a tumour necrosis factor receptor immunoadhesion
37. ++, T cells in lungs following aerosol infection with Mycobacterium tuberculosis
38. Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: Studies with T cell receptor-deficient mutant mice
39. T-cell independent granuloma formation in response to Myrobacterium avium: Role of tumour necrosis factor-alpha and interferon-gamma
40. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions
41. Increased antimycobacterial immunity in interleukin-10-deficient mice
42. Intrapulmonary delivery of tumour necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia
43. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis
44. Stimulation of neutrophils by tumour necrosis factor